Unverified50% confidenceBenchmarkExact time
On a synthetic oncology benchmark, active learning + DP-SGD at ε=3 matched the performance of random sampling + DP-SGD at ε=8 in AUROC.
1
Sources
50%
Confidence
Medium-term (~90 days)
Relevance
10/13/2026
First Seen
Valid until: 1/11/2027
Sources
Related Entities
Related Claims
UnverifiedIn benchmarks, the prototype system requires 3-5 times fewer annotations than random sampling because acquisition is concentrated on borderline cases.59% similarUnverifiedAlphaFold2 combines multiple sequence alignment (MSA) with equivariant neural networks, and for the first time achieved experimental-level prediction accuracy on the majority of proteins, with a median TM-score exceeding 0.9.58% similarUnverifiedA learner, when detecting forged receipts on this dataset, found that regardless of how the model was adjusted, the ROC-AUC consistently hovered between 0.46 and 0.54, close to random guessing.56% similarUnverifiedBased on UNI2-h representations, State-Aware Interaction MIL achieves an AP of 0.5566 on colorectal cancer, surpassing NaiveMTL's 0.5161.54% similarUnverifiedIn prostate cancer prediction on MSK-CHORD, the LLM's cMAE was lower than that of the RSF.53% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1020475API
curl https://kongchang.com/api/v1/knowledge/claims/1020475MCP
get_claim(id=1020475)